Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Clinical trial NCT02128906 · RECRUITING
Trial details
- NCT number
- NCT02128906
- Sponsor
- Christopher Wilke
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-23
- Primary completion
- 2031-12-16
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.